4//SEC Filing
Jones Erika 4
Accession 0001104659-23-022388
CIK 0001701541other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:11 PM ET
Size
7.7 KB
Accession
0001104659-23-022388
Insider Transaction Report
Form 4
Jones Erika
SEE REMARKS
Transactions
- Award
Common Stock
2023-02-13+5,075→ 10,150 total - Award
Stock Option (Right to Buy)
2023-02-13+60,000→ 60,000 totalExercise: $2.92Exp: 2033-02-12→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was previously granted performance-based Restricted Stock Units ("RSUs"). The vesting of 35% of the RSUs was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,776 RSUs, with the remainder vesting on August 15, 2023, subject to the grantee's continuous service through such vesting date.
- [F2]25% of the shares subject to this option shall vest and become exercisable on February 13, 2024, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001895913
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:11 PM ET
- Size
- 7.7 KB